How a Chinese imaging platform is consolidating the OR into a single stack.

UX7 Series Endoscope Camera System (4K, NIR Fluorescence & 3D)

Most endoscope camera systems specialize in one imaging modality. The UX7 Series, developed through full-chain independent R&D, combines three—true 4K resolution, near-infrared fluorescence, and real-time 3D visualization—within a single modular platform. This consolidation is not just a technical feat; it is a procurement strategy aimed at displacing multi-vendor setups in high-volume hospitals.

The system’s dual-chip 4K sensors and intelligent imaging algorithms (autofocus, anti-fog, scene recognition) reduce the cognitive load on surgical teams. NIR fluorescence detects vascular structures and tissue perfusion in real time, giving surgeons objective data on blood supply instead of relying on visual guesswork. The addition of 3D visualization offers depth perception critical for dissection in confined anatomy.

The hardware is straightforward: rigid endoscopes in 10 mm, 5 mm, and 3 mm diameters; 32″ and 55″ medical 4K monitors; dual-channel recording; PACS integration. The camera head weighs 190 g in white-light mode, 240 g with fluorescence—light enough to reduce surgeon fatigue over long procedures.

What matters operationally is the platform’s modularity. The same system can switch between general surgery, urology, gynecology, or thoracic cases by swapping scopes and toggling imaging modes. This eliminates the need for separate carts and tower stacks—a real constraint in crowded ORs.

From a supply-chain perspective, the UX7 represents a deliberate push by Chinese manufacturers to capture the mid-to-high end of surgical visualization. The entire chain—sensors, optics, processing chips, video recording—is controlled in-house, reducing dependency on Japanese or German component suppliers that dominate the endoscopic market.

For hospital procurement teams, the calculus shifts from buying best-in-class components from multiple vendors to a single supplier that guarantees interoperability and support. That lowers total cost of ownership and simplifies training—two variables that matter as much as pixel count in a 500-bed hospital.

The UX7 will not replace the top-tier systems from Olympus or Stryker overnight. But it signals that the architectural advantage has shifted: integration, not raw resolution, now defines the competitive frontier in surgical imaging.

Why it matters:
For buyers, the UX7 reduces vendor complexity and training overhead. For operators, it eliminates equipment-switching friction between procedures. For suppliers, it confirms that full-stack Chinese imaging platforms have reached parity with established European and Japanese systems in core surgical applications.

View Product →